Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Open-Labeled, Multi-Center, Randomized Controlled Trial of Vinblastine +/- Bevacizumab for the Treatment of Chemotherapy-Naïve Children With Unresectable or Progressive Low Grade Glioma (LGG)

NCT02840409 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT02840409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02840409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Open-Labeled, Multi-Center, Randomized Controlled Trial of Vinblastine +/- Bevacizumab for the Treatment of Chemotherapy-Naïve Children With Unresectable or Progressive Low Grade Glioma (LGG)
Lead sponsor
The Hospital for Sick Children
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 1, 2016
Completion date
August 31, 2026
Enrollment
109 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

low grade glioma